BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36061828)

  • 1. Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical approaches in multiple cohorts.
    Li D; Li S; Xia Z; Cao J; Zhang J; Chen B; Zhang X; Zhu W; Fang J; Liu Q; Hua W
    EPMA J; 2022 Sep; 13(3):499-517. PubMed ID: 36061828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis.
    Li S; Xia Z; Cao J; Zhang J; Chen B; Chen T; Zhang X; Zhu W; Li D; Hua W; Mao Y
    Front Immunol; 2022; 13():1039862. PubMed ID: 36439151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients.
    Li M; Xia H; Zheng H; Li Y; Liu J; Hu L; Li J; Ding Y; Pu L; Gui Q; Zheng Y; Zhai Z; Xiong S
    BMC Cancer; 2019 Nov; 19(1):1084. PubMed ID: 31711453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
    Kim S; Nam SJ; Kwon D; Kim H; Lee E; Kim TM; Heo DS; Park SH; Kim CW; Jeon YK
    BMC Cancer; 2016 Jun; 16():363. PubMed ID: 27286976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of Pretreatment Serum Total Bilirubin as a Biomarker to Predict the Clinical Outcomes in Primary Central Nervous System Lymphoma: A Multicenter Cohort Study.
    Cao J; Li S; Li D; Hua W; Guo L; Xia Z
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A promising prognostic model for predicting survival of patients with HIV-related diffuse large B-cell lymphoma in the cART era.
    Chen J; Wu Y; Kang Z; Qin S; Ruan G; Zhao H; Tao X; Xie Z; Peng J
    Cancer Med; 2023 Jun; 12(11):12470-12481. PubMed ID: 37081761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a routine blood parameters-based model for screening the occurrence of retinal detachment in high myopia in the context of PPPM.
    Li S; Li M; Wu J; Li Y; Han J; Cao W; Zhou X
    EPMA J; 2023 Jun; 14(2):219-233. PubMed ID: 37275550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the red blood cell distribution width in diffuse large B-cell lymphoma patients.
    Zhou S; Fang F; Chen H; Zhang W; Chen Y; Shi Y; Zheng Z; Ma Y; Tang L; Feng J; Zhang Y; Sun L; Chen Y; Liang B; Yu K; Jiang S
    Oncotarget; 2017 Jun; 8(25):40724-40731. PubMed ID: 28388534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL.
    Chen J; Wu Y; Zhao H; Ruan G; Qin S
    Front Immunol; 2024; 15():1354325. PubMed ID: 38426083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Role of Red Cell Distribution Width (RDW) in Patients with Diffuse Large B-cell Lymphoma.
    Kamandi N; Soleimanian A; Allahyari A; Kamandi M
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2667-2672. PubMed ID: 37642052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma.
    Song MK; Chung JS; Joo YD; Lee SM; Oh SY; Shin DH; Yun EY; Kim SG; Seol YM; Shin HJ; Choi YJ; Cho GJ
    J Neurooncol; 2011 Sep; 104(3):825-31. PubMed ID: 21380743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of red blood cell distribution width and D-Dimer in diffuse large B-cell lymphoma: Systematic review and meta-analysis.
    Rahchamani M; Sedghi M; Hakimi A; Nejatianfar M; Javaheri T; Tavakoli R; Ahmadi R; Makarem M; Azmi-Naei N; Zahmatkesh Sangani S; Kamandi N; Soleimanian A; Shavaleh R; Foogerdi M; Rahmani K
    Cancer Rep (Hoboken); 2024 Jan; 7(1):e1936. PubMed ID: 37997648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy.
    Beltran BE; Paredes S; Castro D; Cotrina E; Sotomayor EM; Castillo JJ
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e551-e557. PubMed ID: 31320254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a [
    Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
    Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting acupuncture efficacy for functional dyspepsia based on routine clinical features: a machine learning study in the framework of predictive, preventive, and personalized medicine.
    Yin T; Zheng H; Ma T; Tian X; Xu J; Li Y; Lan L; Liu M; Sun R; Tang Y; Liang F; Zeng F
    EPMA J; 2022 Mar; 13(1):137-147. PubMed ID: 35273662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of Red Blood Cell Distribution Width and Fibrinogen Level for Evaluation of the Therapeutic Efficacy and Prognosis in Patients with Diffuse Large B-Cell Lymphoma].
    Wang X; Wu CY; Zeng PY; Li LL; Ma CC; Xiang X; Li YQ; Chai Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):153-159. PubMed ID: 32027269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
    Chen H; Zhong Q; Zhou Y; Qin Y; Yang J; Liu P; He X; Zhou S; Zhang C; Gui L; Yang S; Zhou L; Shi Y
    BMC Cancer; 2022 May; 22(1):583. PubMed ID: 35624433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.
    Liu J; Shi Y; Zhang Y
    EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study.
    Periša V; Zibar L; Sinčić-Petričević J; Knezović A; Periša I; Barbić J
    Croat Med J; 2015 Aug; 56(4):334-43. PubMed ID: 26321026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.
    He M; Zuo C; Wang J; Liu J; Jiao B; Zheng J; Cai Z
    Neuro Oncol; 2013 Jun; 15(6):727-34. PubMed ID: 23482670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.